Mona Lichtblau

ORCID: 0000-0003-4485-1758
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pulmonary Hypertension Research and Treatments
  • High Altitude and Hypoxia
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Neuroscience of respiration and sleep
  • Travel-related health issues
  • Cardiovascular and Diving-Related Complications
  • Cardiovascular and exercise physiology
  • Cardiovascular Function and Risk Factors
  • Respiratory Support and Mechanisms
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Congenital Heart Disease Studies
  • Cardiovascular Issues in Pregnancy
  • Heart Rate Variability and Autonomic Control
  • Heart Failure Treatment and Management
  • Vascular Anomalies and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Climate Change and Health Impacts
  • Spaceflight effects on biology
  • Cardiovascular Effects of Exercise
  • Systemic Sclerosis and Related Diseases
  • Obstructive Sleep Apnea Research
  • Medical Imaging and Pathology Studies
  • Liver Disease and Transplantation
  • Eicosanoids and Hypertension Pharmacology
  • Traumatic Brain Injury and Neurovascular Disturbances

University Hospital of Zurich
2016-2025

University of Zurich
2017-2025

National Center of Cardiology and Internal Medicine
2025

Klinik für Schlafmedizin
2019-2023

Swiss Society of Hypertension
2021

University Hospital of Lausanne
2021

Canadian Respiratory Research Network
2016

Heidelberg University
2010-2015

University Hospital Heidelberg
2010-2015

TU Dresden
2012

Robert C. Roach Peter H. Hackett O Oelz Peter Bärtsch Andrew M. Luks and 87 more Martin J. MacInnis J. Kenneth Baillie Eric Achatz Edi Albert J. Andrews James D. Anholm Mohammad Zahid Ashraf Paul S. Auerbach Buddha Basnyat Beth A. Beidleman Remco R. Berendsen Marc Moritz Berger Konrad E. Bloch Hermann Brugger Annalisa Cogo Ricardo Gonzalez Costa Andrew F. Cumpstey Allen Cymerman Tadej Debevec Catriona Duncan David J. Dubowitz Angela Fago Michaël Furian Matt Gaidica Prosenjit Ganguli Michael P. W. Grocott Debra Hammer David P. Hall David Hillebrandt Matthias P. Hilty Gigugu Himashree Benjamin Honigman Ned Gilbert-Kawai Bengt Kayser Linda E. Keyes Michael S. Koehle Samantha Kohli Arlena Kuenzel Benjamin D. Levine Mona Lichtblau Jamie Macdonald Monika Brodmann Maeder Marco Maggiorini Daniel Martín Shigeru Masuyama John McCall Scott McIntosh Grégoire P. Millet Fernando A. Moraga Craig Mounsey Stephen R. Muza Samuel J. Oliver Qadar Pasha Ryan F. Paterson Lara Phillips Aurélien Pichon Philipp A. Pickerodt Matiram Pun Manjari Rain Drummond Rennie Ri‐Li Ge Steven Roy Samuel Vergès Tatiana Batalha Cunha dos Santos Robert B. Schoene Otto D. Schoch SP Singh Talant Sooronbaev Craig D. Steinback Mike Stembridge Glenn M. Stewart Tsering Stobdan Giacomo Strapazzon Andrew W. Subudhi Erik R. Swenson A. A. Roger Thompson Martha C. Tissot van Patot Rosie Twomey Silvia Ulrich Nicolas Voituron Dale R. Wagner Shih-hao Wang John B. West Matt Wilkes Gabriel Willmann Michael Yaron Ken Zafren

Roach, Robert C., Peter H. Hackett, Oswald Oelz, Bärtsch, Andrew M. Luks, Martin J. MacInnis, Kenneth Baillie, and The Lake Louise AMS Score Consensus Committee. 2018 Acute Mountain Sickness Score. High Alt Med Biol 19:1-4, 2018.- (AMS) scoring system has been a useful research tool since first published in 1991. Recent studies have shown that disturbed sleep at altitude, one of the five symptoms scored for AMS, is more likely due to altitude hypoxia per se, not closely related AMS. To...

10.1089/ham.2017.0164 article EN High Altitude Medicine & Biology 2018-03-01

The objective of this prospective study was to assess safety and efficacy exercise training in a large cohort patients with different forms World Health Organization (WHO) functional classes chronic pulmonary hypertension (PH). 183 PH (pulmonary arterial (PAH), thromboembolic due respiratory or left heart diseases received hospital for 3 weeks continued at home. Adverse events have been monitored during the in-hospital programme. Efficacy parameters were evaluated baseline, after 15 weeks....

10.1183/09031936.00123711 article EN European Respiratory Journal 2012-02-09

The impact of exercise training on the right heart and pulmonary circulation has not yet been invasively assessed in patients with hypertension (PH) failure. This prospective randomized controlled study investigates effects peak VO2/kg, haemodynamics, further clinically relevant parameters PH patients. Eighty-seven arterial inoperable chronic thrombo-embolic (54% female, 56 ± 15 years, 84% World Health Organization functional class III/IV, 53% combination therapy) stable disease-targeted...

10.1093/eurheartj/ehv337 article EN cc-by-nc European Heart Journal 2015-07-31

Abstract Introduction The objective of this prospective study was to assess short- and long-term efficacy exercise training (ET) as add-on medical therapy in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-APAH). Methods Patients invasively confirmed CTD-APAH received ET in-hospital for 3 weeks continued at home 12 weeks. Efficacy parameters have been evaluated baseline after 15 by blinded-observers. Survival rate has a follow-up period 2.9 ± 1.9...

10.1186/ar3883 article EN cc-by Arthritis Research & Therapy 2012-06-18

Coronavirus disease 19 (COVID-19) is a rapidly evolving pandemic caused by the coronavirus Sars-CoV-2. Clinically manifest central nervous system symptoms have been described in COVID-19 patients and could be consequence of commonly associated vascular pathology, but detailed neuropathological sequelae remain largely unknown. A total six cases, all positive for Sars-CoV-2, showed evidence cerebral petechial hemorrhages microthrombi at autopsy. Two out an elevated risk disseminated...

10.1111/nan.12677 article EN Neuropathology and Applied Neurobiology 2020-11-29

Background In this study, we investigated the impact of new haemodynamic definition pulmonary arterial hypertension (PAH) as proposed by 6th PH World Symposium on phenotypes and survival in patients with systemic sclerosis (SSc). Methods SSc who were prospectively consecutively screened for PAH including right heart catheterisation Heidelberg or Zurich, clinical variables have been reassessed according to definition. Patients followed 3.7±3.7 (median 3.4) years; Kaplan-Meier analysis was...

10.1136/annrheumdis-2019-216476 article EN Annals of the Rheumatic Diseases 2019-12-09

The aim of the present study was to investigate prognostic value exercise haemodynamics measured during right heart catheterisation (RHC) in patients with systemic sclerosis (SSc) referred for evaluation pulmonary hypertension. SSc undergoing RHC at rest and maximal supine incremental cycle were grouped into resting precapillary hypertension (PH ) (mean artery pressure (mPAP) ≥25 mmHg, wedge <15 mmHg), exercise-induced ex (mPAP ≥30 mmHg mPAP/cardiac output >3 mmHg·L −1 ·min exercise),...

10.1183/13993003.00990-2016 article EN European Respiratory Journal 2016-10-06

Objective To investigate the effect of a daylong exposure to high altitude on peak exercise capacity and safety in stable patients with pulmonary arterial chronic thromboembolic hypertension (PAH/CTEPH). Methods In randomised controlled cross-over trial, PAH or distal CTEPH without resting hypoxemia at low performed two incremental tests exhaustion, one after 3–5 h (2500 m) (470 m). Results 27 PAH/CTEPH (44% women, 61±14 y), maximal work-rate was 110±64 watts 2500 m 123±64 470 (−11%, 95%CI:...

10.1183/13993003.01001-2023 article EN cc-by-nc European Respiratory Journal 2024-02-29

Objective: Neurocognitive functions are affected by high altitude, however the altitude effects of acclimatization and repeated exposures unclear. We investigated acute, subacute exposure to 5,050 m on cognition among altitude-naïve participants compared control subjects tested at low altitude. Methods: Twenty-one individuals (25.3 ± 3.8 years, 13 females) were exposed for 1 week (Cycle 1) re-exposed after a rest sea-level 2). Baseline (BL, 520 m), acute (Day 1, HA1) 6, HA6, m) measurements...

10.3389/fphys.2018.01131 article EN cc-by Frontiers in Physiology 2018-08-21

Study question We investigated whether domiciliary oxygen therapy (DOXT) increases exercise capacity and quality of life in patients with pulmonary arterial or distal chronic thromboembolic hypertension (PAH/CTEPH) presenting mild resting hypoxaemia exercise-induced desaturation. Materials methods 30 PAH/CTEPH, mean± sd age 60±15 years, artery pressure 39±11 mmHg, saturation measured by pulse oximetry ( S pO 2 ) ≥90%, drop during a 6-min walk test ≥4%, on hypertension-targeted medication,...

10.1183/13993003.002762019 article EN European Respiratory Journal 2019-05-09

Background The aim of the present work was to study influence body position on resting and exercise pulmonary hemodynamics in patients assessed for hypertension (PH). Methods Results Data from 483 with suspected PH undergoing right heart catheterization clinical indications (62% women, age 61±15 years, 246 precapillary PH, 48 postcapillary 106 83 no PH) were analyzed; 213 (main cohort, years 2016-2018) examined at rest upright (45°) supine position, such as under exercise. Upright compared...

10.1161/jaha.121.023839 article EN cc-by-nc-nd Journal of the American Heart Association 2022-02-12

Abstract Pollution and climate change constitute a combined, grave pervasive threat to humans the life‐support systems on which they depend. Evidence shows strong association between pollution cardiovascular respiratory diseases, pulmonary vascular disease (PVD) is no exception. An increasing number of studies has documented impact environmental extreme temperatures circulation right heart, severity outcomes patients with arterial hypertension chronic thromboembolic (PH), incidence embolism,...

10.1002/pul2.12394 article EN cc-by-nc Pulmonary Circulation 2024-04-01

OBJECTIVE High altitude hypoxia may affect cognitive performance and sleep quality. Further, vigilance is reduced following deprivation. We investigated the effect on vigilance, actigraphic indices their relationships with acute mountain sickness (AMS) during very high (HA) exposure, acclimatization, re-exposure. METHODS Twenty-one healthy altitude-naive individuals (25±4 years; 13 females) completed two cycles of exposure separated by 7 days at low (LA, 520m). Participants slept 2900m spent...

10.3389/fphys.2018.00677 article EN cc-by Frontiers in Physiology 2018-06-04

The question addressed by the study Chronic exposure to hypoxia increases pulmonary artery pressure (PAP) in highlanders, but criteria for diagnosis of high-altitude hypertension (HAPH) are debated. We assessed cardiac function and PAP highlanders at 3250 m explored HAPH prevalence using different definitions. Patients methods Central Asian free overt cardiorespiratory disease, permanently living 2500–3500 compared age-matched lowlanders <800 m. Participants underwent echocardiography...

10.1183/13993003.02474-2019 article EN European Respiratory Journal 2020-05-19

Introduction: Since pregnancy in women with pulmonary arterial hypertension (PAH) is associated a high risk of morbidity and mortality, it recommended that should be avoided PAH. However, some mild PAH may consider this recommendation as unsuitable. Unfortunately knowledge on outcomes best management during limited. Methods: Data from all who were followed by multidisciplinary team at tertiary referral center for delivered between 2004 2020 retrospectively analyzed case series. factor...

10.3389/fmed.2021.689764 article EN cc-by Frontiers in Medicine 2021-07-05

Pure oxygen breathing (hyperoxia) may improve hemodynamics in patients with pulmonary hypertension (PH) and allows to calculate right-to-left shunt fraction (Qs/Qt), whereas normobaric hypoxia accelerate hypoxic vasoconstriction (HPV). This study investigates how hyperoxia affect mean artery pressure (mPAP) vascular resistance (PVR) PH whether Qs/Qt influences the changes of mPAP PVR.Adults arterial or chronic thromboembolic (PAH/CTEPH) underwent repetitive hemodynamic blood gas measurements...

10.3389/fmed.2022.791423 article EN cc-by Frontiers in Medicine 2022-02-11

Acetazolamide (AZA) improves nocturnal and daytime blood oxygenation in patients with pulmonary vascular disease (PVD), defined as arterial distal chronic thromboembolic hypertension (CTEPH), may improve exercise performance.

10.1159/000536399 article EN Respiration 2024-01-01

Background Hypoxic pulmonary vasoconstriction leads to an increase in artery pressure (PAP) and potentially right heart failure healthy individuals patients with respiratory diseases. Previous studies chronic obstructive disease (COPD) exposed hypobaric hypoxia have shown PAP, while traditional echocardiographic parameters revealed only minimal changes at high altitude. Speckle-tracking-derived analysis is more sensitive assess ventricular (RV) function we used this method investigate the...

10.1136/openhrt-2024-002837 article EN cc-by-nc-nd Open Heart 2025-01-01

Häfliger, Alina, Aline Buergin, Laura C. Mayer, Maamed Mademilov, Mona Lichtblau, Talantbek Sooronbaev, Silvia Ulrich, Konrad E. Bloch, and Michael Furian. Sex-specific difference in health-related altitude-effects their prevention by acetazolamide. Data from a randomized controlled trial.

10.1089/ham.2024.0011 article EN High Altitude Medicine & Biology 2025-01-08
Coming Soon ...